{
    "Trade/Device Name(s)": [
        "Elecsys CK-MB STAT Immunoassay",
        "CK-MB STAT Assay"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K140404",
    "Predicate Device Reference 510(k) Number(s)": [
        "K132571"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHY"
    ],
    "Summary Letter Date": "May 8, 2014",
    "Summary Letter Received Date": "April 8, 2014",
    "Submission Date": "April 7, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase isozymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "MB isoenzyme of creatine kinase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "K3-EDTA tube",
        "Lithium heparin tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas e 601 immunoassay analyzer",
        "Elecsys immunoassay analyzers",
        "cobas e immunoassay analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescent immunoassay (ECLIA)",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys CK-MB STAT Immunoassay, a sandwich electrochemiluminescent assay for creatine kinase MB isoenzyme on cobas e and Elecsys analyzers",
    "Indications for Use Summary": "In vitro quantitative determination of the MB isoenzyme of creatine kinase in human serum and plasma as an aid in the diagnosis of myocardial infarction",
    "fda_folder": "Clinical Chemistry"
}